Sun Zhaoqing, Hao Yongchen, Liu Jun, Yang Na, Qi Yue, Hu Danqing, Yang Yiqian, Wang Haimei, Zhao Dong, Sang Caihua, Liu Jing
Center for Clinical and Epidemiologic Research, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China.
Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Front Cardiovasc Med. 2022 Aug 1;9:970787. doi: 10.3389/fcvm.2022.970787. eCollection 2022.
The status of hypertension in patients with atrial fibrillation (AF) remains unknown in China.
This study used data from patients hospitalized with AF recruited by the Improving Care for Cardiovascular Disease in China-AF (CCC-AF) project from 236 hospitals enrolled by geographic-economic level in China from 2015 to 2019. The prevalence, awareness, treatment, and control rates of hypertension in patients hospitalized with AF were estimated. Multivariable logistic regression was used to analyze the factors associated with uncontrolled hypertension.
Among 60,390 patients hospitalized with AF, the prevalence of hypertension according to the 2018 Chinese hypertension guidelines was 66.1%. The awareness, treatment, and control rates of hypertension were 80.3, 55.8, and 39.9%, respectively. Among patients treated for hypertension, the treatment control rate was 46.2%. These rates varied according to patient clinical characteristics and geographic regions. The young (18-44 and 45-54 years old), rural insurance, alcohol drinking, history of heart failure, valvular AF, first diagnosed AF, and permanent AF, were associated with uncontrolled hypertension. Under the 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines, the prevalence of hypertension was 79.3%, and the control and treatment control rates dropped to 16.7 and 21.2%, respectively.
Hypertension is common in patients hospitalized with AF in China. Although most patients were aware of their hypertensive status, the treatment and control rates of hypertension were still low. The management of hypertension in patients with AF needs to be further improved.
心房颤动（AF）患者的高血压状况在中国仍不清楚。
本研究使用了中国心血管疾病改善项目-AF（CCC-AF）从2015年至2019年在中国按地理经济水平纳入的236家医院招募的房颤住院患者的数据。估计了房颤住院患者高血压的患病率、知晓率、治疗率和控制率。采用多变量逻辑回归分析与高血压未控制相关的因素。
在60390例房颤住院患者中，根据2018年中国高血压指南，高血压患病率为66.1%。高血压的知晓率、治疗率和控制率分别为80.3%、55.8%和39.9%。在接受高血压治疗的患者中，治疗控制率为46.2%。这些率因患者临床特征和地理区域而异。年轻人（18-44岁和45-54岁）、农村医保、饮酒、心力衰竭病史、瓣膜性房颤、初诊房颤和永久性房颤与高血压未控制相关。根据2017年美国心脏病学会/美国心脏协会（ACC/AHA）高血压指南，高血压患病率为79.3%，控制率和治疗控制率分别降至16.7%和21.2%。
高血压在中国房颤住院患者中很常见。虽然大多数患者知晓自己的高血压状况，但高血压的治疗率和控制率仍然很低。房颤患者的高血压管理需要进一步改善。
